Skip to main content

Month: June 2020

ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist and CD73 Inhibitor Programs at the 2020 American Association for Cancer Research Virtual Annual Meeting II

SOUTH SAN FRANCISCO, Calif., June 22, 2020 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today presented preclinical data from the company’s glucocorticoid receptor (GR) antagonist and CD73 inhibitor programs in five poster presentations during the ongoing American Association for Cancer Research (AACR) Virtual Annual Meeting II.“We are pleased to be able to present these compelling preclinical data from our ORIC-101 and CD73 programs, which continue to validate our scientific platform focused on overcoming therapeutic resistance in cancer,” said Lori Friedman, chief scientific officer. “In particular, we are encouraged to see ORIC-101 reversing GR-mediated resistance in a variety of tumor models,...

Continue reading

Dynavax to Present at the H.C. Wainwright Virtual Fireside Chat Series

EMERYVILLE, Calif., June 22, 2020 (GLOBE NEWSWIRE) — Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that Ryan Spencer, Chief Executive Officer, will participate in a virtual fireside chat at the H.C. Wainwright Virtual Fireside Chat Series on Thursday, June 25, at 10:50 a.m. E.T.The presentation will be webcast and may be accessed through the “Events & Presentations” page on the “investors” section of the Company’s website at http://investors.dynavax.com/events-presentations.About DynavaxDynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company launched its first commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], in February 2018, following...

Continue reading

12 ReTech Corporation Released its Annual Report for the Year Ended December 31, 2019.

The Company reports an annual revenue increase of $1,535,776 year over year!Las Vegas, NV & Hong Kong, June 22, 2020 (GLOBE NEWSWIRE) — 12 ReTech Corporation (OTC: RETC), announced today that it has filed its annual Form 10-K with the United States Securities and Exchange Commission for the year ended December 31, 2019. These financial results represent the combined operations of 12 Hong Kong, Ltd., 12 Japan, Ltd., 12 Europe AG and Emotion Fashion Group, Inc. (“EFG”) during the entire 12 month period ended December 31, 2019 and also include the financial results from the dates of acquisition through December 31, 2019 for Red Wire Group, LLC (“RWG”), Rune NYC, LLC (“Rune”), Bluwire Group, LLC (“Bluwire”) and Social Decay, LLC (“Social Sunday”) which were each acquired on various dates during 2019.For the 12-month period ended...

Continue reading

AnPac Bio Launches New Immunology Test Product Line

SAN JOSE, Calif., June 22, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that  the Company launched a new immunology test product line in China during the week of June 15, 2020.  This immunology test product line consists of multiple government-approved immunology related tests, and relies on AnPac Bio’s novel multi-level, multi-parameter scientific approach and expertise along with our proprietary algorithms.Given the evidence of correlation between degradation in human immune system and cancer occurrence and diseases such as COVID-19, there has been increasing interest in immunology related tests and risk assessments. According...

Continue reading

HIRE Technologies & RSI International Systems Mutually Terminate Transaction to Combine

VANCOUVER, British Columbia, June 22, 2020 (GLOBE NEWSWIRE) — HIRE Technologies Inc. (TSX-V: HIRE) (“HIRE”) and RSI International Systems Inc. (NEX: RSY.H) (“RSI”) have mutually agreed to terminate their agreement to combine or amalgamate, as announced in a press release dated February 21, 2020. Neither party must pay the other a termination fee because of the mutual decision to terminate the agreement.About RSI International SystemsRSI International Systems Inc. sold its only business asset, RoomKeyPMS, in early 2019. The Company is now seeking to use the net sale proceeds to invest in a new business.About HIRE TechnologiesHIRE is focused on the acquisition of information technology, staffing, and HR consulting firms. We provide our partners with meaningful cross-selling opportunities, access to leading technology,...

Continue reading

Preclinical Data from Assembly Biosciences’ Immuno-Oncology Microbiome Program Featured at AACR’s Virtual Annual Meeting II

SOUTH SAN FRANCISCO, Calif., June 22, 2020 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome, today announced that preclinical data from its immuno-oncology microbiome program are currently being featured in an e-poster at the American Association for Cancer Research Virtual Annual Meeting II, June 22-24, 2020. The poster, Discovery and functional validation of a rationally selected, orally administered, live biotherapeutic consortium of commensal bacteria for the treatment of solid tumors, is also available in the Investors section of Assembly’s website: https://investor.assemblybio.com/events-presentations.“There is growing evidence supporting the role of gut commensal...

Continue reading

FuelCell Energy Resumes Manufacturing at Torrington Facility

DANBURY, Conn., June 22, 2020 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL) — a global leader in fuel cell technology – with a purpose of utilizing its proprietary, state-of-the-art fuel cell platforms to enable a world empowered by clean energy – announced that it has resumed manufacturing at its Torrington, CT facility. The Company previously announced that it had temporarily suspended manufacturing activities on March 18, 2020 in light of the COVID-19 outbreak as a proactive and voluntary measure to secure the safety of the Company’s employees and the communities in which our employees live. All team members affected by the temporary shutdown have remained employed by the Company and have received full pay and benefits for the duration of the temporary shutdown.By implementing work from home practices and continuing...

Continue reading

La Sierra University to Deploy OMNIQ’s Artificial Intelligence – Cloud Based Access Control Parking and Security System

University will implement  the cloud-based Permitting, Enforcement and Revenue Citation System (PERCS), significantly improving campus safety and enabling virtual access control, parking and revenue collectionSystem uses OMNIQ’s  AI-Machine Vision vehicle recognition technology to improve Public Safety, Automation and Smart City projectsLa Sierra University deployment follows recent orders for the Company’s AI based Smart City solution from the City of San Mateo in California and the Baltimore Talmudical AcademyLa Sierra University has approximately 2,500 students and 700 employeesSALT LAKE CITY, June 22, 2020 (GLOBE NEWSWIRE) — OMNIQ, Inc. (OTCQB:OMQS) (“OMNIQ”or “the Company”),  announces that it has received a follow-on order to upgrade the access control and parking system at La Sierra University in Riverside, California with...

Continue reading

UFP Technologies to Host Virtual 1×1 Investor Meetings at the 10th Annual East Coast IDEAS Investor Conference on June 23 & 24

NEWBURYPORT, Mass., June 22, 2020 (GLOBE NEWSWIRE) — UFP Technologies (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Ron Lataille, Chief Financial Officer, will be hosting virtual one-on-one meetings with investors during the virtual East Coast IDEAS Investor Conference on June 23-24, 2020.  Investors interested in participating in the virtual conference or scheduling a meeting with the Company may reach out to Jeff Elliott with Three Part Advisors, LLC at 972-423-7070. UFP Technologies is an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market. Utilizing highly specialized foams, films, and plastics, the Company converts raw materials...

Continue reading

Bulletin from Bilia’s Annual General Meeting 2020

Bilia AB’s AGM took place on Monday 22 June 2020, in Stockholm, Sweden.Adoption of the profit and loss statements and balance sheetsThe profit and loss statements and the balance sheets of the parent company and the Group for the financial year 2019 were approved.Appropriation of the profitIn accordance with the proposal of the Board, it was decided that no dividend for the financial year 2019 is to be paid and that the earnings available for distribution shall be carried forward to a new account.Number of board members and election of the Board of DirectorsThe AGM resolved that the Board of Directors shall consist of nine ordinary board members without deputy members. Ingrid Jonasson Blank, Gunnar Blomkvist, Anna Engebretsen, Eva Eriksson, Mats Holgerson, Nicklas Paulson, Jan Pettersson, Mats Qviberg and Jon Risfelt were re-elected as...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.